AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

Trump announced his decision in a tweet following media reports that Kennedy would be his choice to lead the federal health ...

By registering you consent to the collection and use of your information to provide the products and services you have ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

Michelle Peters Wellington announced Thursday that she has joined Vistagen Therapeutics as VP of communications. MM+M’s third ...

As Merck prepares for its blockbuster immunotherapy Keytruda to face generic competition, it’s investing in a new cancer drug from LaNova.